Paolo Siciliano, Cell and Gene Expert, PA ConsultingFrom Paolo Siciliano, Cell and Gene Expert, PA ConsultingAll TechnologyFive Key Manufacturing Challenges in Autologous Commercial Cell and Gene TherapiesThe personalized nature of autologous CGT results in complex manufacturing challenges, driving costs high when transitioning from clinical to commercial scale.February 5, 2024Page 1 of 1
